Search Results 211-220 of 13855 for Assay
Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia. Cancers ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. A Phase I/II, open-label, multi-center ...
... assay. A database of paired clinical and sequencing data will also be established for future research. Study of Breast Cancer Risk Assessment in Female ...
Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...
The purpose of this study is to obtain Granulocytes from donors with known HNA phenotype are needed for clinical HNA assay. Participation eligibility.
... assays using patient peripheral blood immune cells or serum. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
... assay, and to evaluate the use of SARS-CoV-2 viral load measured in saliva for correlation with levels in other specimen types, disease course, and/or ...
... assay. This will be done by comparing pre-and-post MRI hs-cTnT levels in these patients. Participation eligibility. Participant eligibility includes age ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.